Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

William E Carson

Showing results (251-260 of 272) with videos related to

Pageof 28
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 31, 2017
Phase III Randomized Study of 4 Weeks of High-Dose Interferon-α-2b in Stage T2bNO, T3a-bNO, T4a-bNO, and T1-4N1a-2a (microscopic) Melanoma: A Trial of the Eastern Cooperative Oncology Group-American College of Radiology Imaging Network Cancer Research Group (E1697)Sanjiv S Agarwala, Sandra J Lee, Waiki Yip, et al.
Blood|March 23, 2021
Phase 2 study of ibrutinib in classic and variant hairy cell leukemiaKerry A Rogers, Leslie A Andritsos, Lai Wei, et al.
The Lancet. Oncology|December 8, 2025
Cancer mortality rates by detailed occupation among US working-age adults between 2020 and 2023: a population-based studyJacob D Lesinski, Jingbo Yi, Elizabeth Ghias, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 31, 2019
A Phase I/II Trial of Cetuximab in Combination with Interleukin-12 Administered to Patients with Unresectable Primary or Recurrent Head and Neck Squamous Cell CarcinomaElizabeth L McMichael, Brooke Benner, Lakhvir S Atwal, et al.
Cell Reports|May 20, 2023
Microenvironmental control of hematopoietic stem cell fate via CXCL8 and protein kinase CVera Binder, Wantong Li, Muhammad Faisal, et al.
The Journal of Clinical Investigation|August 5, 2025
BRD4 inhibition leads to MDSC apoptosis and enhances checkpoint blockade therapyHimanshu Savardekar, Andrew Stiff, Alvin Liu, et al.
JCI Insight|November 8, 2024
Inhibition of Bruton's tyrosine kinase with PD-1 blockade modulates T cell activation in solid tumorsEmily Schwarz, Brooke Benner, Robert Wesolowski, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|March 7, 2012
MelanomaDaniel G Coit, Robert Andtbacka, Christopher J Anker, et al.
Cancer Immunology Research|February 12, 2016
NK Cell-Mediated Antitumor Effects of a Folate-Conjugated Immunoglobulin Are Enhanced by CytokinesAlena C Jaime-Ramirez, Elizabeth McMichael, SriVidya Kondadasula, et al.
Journal of Immunology (Baltimore, Md. : 1950)|August 5, 2015
The Raf Kinase Inhibitor Sorafenib Inhibits JAK-STAT Signal Transduction in Human Immune CellsSara E Martin del Campo, Kala M Levine, Bethany L Mundy-Bosse, et al.
Pageof 28

Showing results (251-260 of 272) with videos related to

Sort By:
Pageof 28
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 31, 2017
Phase III Randomized Study of 4 Weeks of High-Dose Interferon-α-2b in Stage T2bNO, T3a-bNO, T4a-bNO, and T1-4N1a-2a (microscopic) Melanoma: A Trial of the Eastern Cooperative Oncology Group-American College of Radiology Imaging Network Cancer Research Group (E1697)Sanjiv S Agarwala, Sandra J Lee, Waiki Yip, et al.
Blood|March 23, 2021
Phase 2 study of ibrutinib in classic and variant hairy cell leukemiaKerry A Rogers, Leslie A Andritsos, Lai Wei, et al.
The Lancet. Oncology|December 8, 2025
Cancer mortality rates by detailed occupation among US working-age adults between 2020 and 2023: a population-based studyJacob D Lesinski, Jingbo Yi, Elizabeth Ghias, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 31, 2019
A Phase I/II Trial of Cetuximab in Combination with Interleukin-12 Administered to Patients with Unresectable Primary or Recurrent Head and Neck Squamous Cell CarcinomaElizabeth L McMichael, Brooke Benner, Lakhvir S Atwal, et al.
Cell Reports|May 20, 2023
Microenvironmental control of hematopoietic stem cell fate via CXCL8 and protein kinase CVera Binder, Wantong Li, Muhammad Faisal, et al.
The Journal of Clinical Investigation|August 5, 2025
BRD4 inhibition leads to MDSC apoptosis and enhances checkpoint blockade therapyHimanshu Savardekar, Andrew Stiff, Alvin Liu, et al.
JCI Insight|November 8, 2024
Inhibition of Bruton's tyrosine kinase with PD-1 blockade modulates T cell activation in solid tumorsEmily Schwarz, Brooke Benner, Robert Wesolowski, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|March 7, 2012
MelanomaDaniel G Coit, Robert Andtbacka, Christopher J Anker, et al.
Cancer Immunology Research|February 12, 2016
NK Cell-Mediated Antitumor Effects of a Folate-Conjugated Immunoglobulin Are Enhanced by CytokinesAlena C Jaime-Ramirez, Elizabeth McMichael, SriVidya Kondadasula, et al.
Journal of Immunology (Baltimore, Md. : 1950)|August 5, 2015
The Raf Kinase Inhibitor Sorafenib Inhibits JAK-STAT Signal Transduction in Human Immune CellsSara E Martin del Campo, Kala M Levine, Bethany L Mundy-Bosse, et al.
Pageof 28